Infliximab and Methotrexate Interaction

Drug interaction information between Infliximab and Methotrexate.

Infliximab and Methotrexate have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Infliximab and Methotrexate. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Infliximab

TNF-Alpha Inhibitor (Biologic)

Drug B

Methotrexate

Disease-Modifying Antirheumatic Drug (DMARD)

How They Interact

There is no specific information available on how these two drugs interact because clinical studies have not been performed.

FDA Label Information

7.2 Methotrexate and Other Concomitant Medications Specific drug interaction studies, including interactions with methotrexate (MTX), have not been conducted.

Methotrexate Also Interacts With

View all Methotrexate interactions →

Frequently Asked Questions

What SPL severity band is on file for Infliximab + Methotrexate?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Methotrexate has 38 labeled pairs on file vs Infliximab's 8. In the minor band specifically: Infliximab has 7 (also Folic Acid, Warfarin, Ciprofloxacin, Cyclosporine); Methotrexate has 26 (also Aspirin, Folic Acid, Probenecid, Phenytoin).

What mechanism field is on file for Infliximab and Methotrexate?

There is no specific information available on how these two drugs interact because clinical studies have not been performed.

Methotrexate's labeled portfolio outnumbers Infliximab

SPL source-record counts only. This page's band is minor · classes on file: Infliximab (TNF-Alpha Inhibitor (Biologic)); Methotrexate (Disease-Modifying Antirheumatic Drug (DMARD)).

Infliximab

0 major · 1 moderate · 7 minor · 8 total

Methotrexate

0 major · 12 moderate · 26 minor · 38 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.